Carregant...
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
BACKGROUND: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are treatment-resistant. The only evidence-based treatment for these patients is clozapine, an atypical antipsychotic with relatively weak dopamine antagonism. It is plausible that varying degrees of respons...
Guardat en:
| Publicat a: | BMC Psychiatry |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237235/ https://ncbi.nlm.nih.gov/pubmed/28086761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-016-1177-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|